Synthetic Strategies for Dustats: Comprehensive Review of Contemporary Methodological Approaches
Synthesis · 01.06.2026 · 58 (12) · 1307-1320
DOI: 10.1055/a-2831-0436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 01.06.2026. Verfasst von Karuna Sree Kunta und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHs) represent a persuasive area of research, due to their therapeutic potential in treating anemia associated with chronic kidney disease (CKD). Synthetic approaches to HIF-PHs often focus on designing small molecules that can inhibit prolyl hydroxylase enzymes, which regulate the stability and activity of hydroxylase inhibitors. The “-dustats” are a class of small-molecule PHs, representing a significant advancement in oral therapies for anemia associated with CKD. Anemia is a common complication of CKD, a long-term condition in which the kidneys are damaged. This review aims to provide a detailed analysis of the various synthetic approaches employed in developing dustat drugs, as documented in the literature, while highlighting the latest advancements and innovations in this evolving field.
Zitieren
APA
Kunta, K. S., & Godumala, M. (2026). Synthetic Strategies for Dustats: Comprehensive Review of Contemporary Methodological Approaches. Synthesis, 58(12), 1307-1320. https://doi.org/10.1055/a-2831-0436
Vancouver
Kunta KS, Godumala M. Synthetic Strategies for Dustats: Comprehensive Review of Contemporary Methodological Approaches. Synthesis. 2026;58(12):1307-1320. doi:10.1055/a-2831-0436
BibTeX
@article{Kunta2026,
author = {Kunta, Karuna Sree and Godumala, Mallesham},
title = {Synthetic Strategies for Dustats: Comprehensive Review of Contemporary Methodological Approaches},
journal = {Synthesis},
year = {2026},
volume = {58},
number = {12},
pages = {1307--1320},
doi = {10.1055/a-2831-0436}
}
EUVIMED